Balyasny Asset Management LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Balyasny Asset Management LLC

  • $54.8 Billion
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$98.98 - $115.74 $7.79 Million - $9.11 Million
-78,700 Reduced 9.78%
726,000 $84 Million
Q2 2023

Aug 14, 2023
BUY
$96.34 - $112.38 $77.5 Million - $90.4 Million
804,700 New
804,700 $82.8 Million
Q4 2022

Feb 14, 2023
BUY
$62.39 - $113.8 $115 Million - $209 Million
1,838,000 Added 13128.57%
1,852,000 $211 Million
Q3 2022

Nov 14, 2022
BUY
$58.92 - $84.67 $824,880 - $1.19 Million
14,000 New
14,000 $866,000

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email